Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) EBT Margin (2016 - 2025)

Rockwell Medical's EBT Margin history spans 16 years, with the latest figure at 3.49% for Q4 2025.

  • For Q4 2025, EBT Margin fell 33.0% year-over-year to 3.49%; the TTM value through Dec 2025 reached 8.06%, down 751.0%, while the annual FY2025 figure was 8.06%, 751.0% down from the prior year.
  • EBT Margin reached 3.49% in Q4 2025 per RMTI's latest filing, up from 11.39% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 5.88% in Q3 2024 to a low of 58.32% in Q4 2021.
  • Average EBT Margin over 5 years is 19.85%, with a median of 10.54% recorded in 2025.
  • Peak YoY movement for EBT Margin: tumbled -1738bps in 2021, then surged 4609bps in 2022.
  • A 5-year view of EBT Margin shows it stood at 58.32% in 2021, then soared by 79bps to 12.23% in 2022, then skyrocketed by 40bps to 7.3% in 2023, then surged by 57bps to 3.16% in 2024, then fell by -10bps to 3.49% in 2025.
  • Per Business Quant, the three most recent readings for RMTI's EBT Margin are 3.49% (Q4 2025), 11.39% (Q3 2025), and 9.68% (Q2 2025).